$AMRS Oppenheimer reiterated their buy rating with a $9.00 price objective on the biotechnology company's stock.
$AMRS Oppenheimer reiterated their buy rating with a $9.00 price objective on the biotechnology company's stock.
— AllCEUs Counselor Education with Dawn-Elise Snipes (@All_CEUs) September 14, 2020
from Twitter https://twitter.com/All_CEUs
September 14, 2020 at 07:26AM
via IFTTT
Comments
Post a Comment